Phenylpiracetam Hydrazide 200 mg – 30 capsules
research-grade
capsule formulation
in a sealed bottle. Phenylpiracetam hydrazide (also known as fonturacetam hydrazide) is studied in experimental models of synaptic plasticity, glutamatergic transmission and cognition-related pathways.
Research Use Only:
All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.
Purity
High-purity research grade
Content
200 mg Phenylpiracetam Hydrazide per capsule; 30 capsules per bottle
Packaging
Capsule bottle (sealed, tamper-evident closure)
Storage
Store at room temperature in a dry place; protect from light
Molecular formula
C12H15N3O2
Molecular weight
~233.27 g·mol⁻¹
Research Overview
Phenylpiracetam hydrazide is explored as a research analog within the racetam family to probe mechanisms of neuroplasticity and excitation–inhibition balance. In vitro and in vivo models evaluate its influence on glutamatergic signaling, synaptic markers and cognition-associated pathways without implying therapeutic use.
Primary Research Areas
-
Synaptic plasticity: Models assessing long-term potentiation (LTP), synaptic density and plasticity-associated protein expression.
-
Glutamatergic transmission: In vitro assays and animal studies focused on NMDA/AMPA receptor-related cascades and downstream signaling.
-
Cognition & performance paradigms: Research evaluating attention, working memory and task performance in controlled laboratory settings.
